Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma: Prognostic implications
Authors:
- V.E. TheodoropoulosVTV.E. Theodoropoulos
- A. TsigkaATA. Tsigka
- A. MihalopoulouAMA. Mihalopoulou
- V. TsoukalaVTV. Tsoukala
- A.C. LazarisALA.C. Lazaris
- E. PatsourisEPE. Patsouris
- I. GhikontiIGI. Ghikonti
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- THE EXPRESSION OF NEUROPEPTIDES IN HYPERPLASTIC AND MALIGNANT PROSTATE TISSUE AND ITS POSSIBLE CLINICAL IMPLICATIONSJournal of Urology, 2001
- Neurogenic origin of human prostate endocrine cellsUrology, 1999
- Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspectsUrology, 1998
- Neuroendocrine differentiation and prognosis in prostatic adenocarcinomaBritish Journal of Urology, 1997
- Neuroendocrine differentiation in prostate cancer: Enhanced prediction of progression after radical prostatectomyHuman Pathology, 1996
- Plasma Neuroendocrine Markers in Patients with Benign Prostatic Hyperplasia and Prostatic CarcinomaJournal of Urology, 1996
- Neuroendocrine differentiation in prostatic carcinoma. Recent findings and new conceptsCancer, 1995
- Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implicationsCancer, 1992
- Neuro‐endocrine Cells—A New Prognostic Parameter in Prostate CancerBritish Journal of Urology, 1991
- Incidental Carcinoma of the Prostate: An Analysis of the Predictors of ProgressionJournal of Urology, 1988